COELHO PHILIP H 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 6, 2021
Insider Transaction Report
Form 4
COELHO PHILIP H
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2021-12-03+1,333→ 239,553 total - Award
Restricted Stock Units
2021-12-03−1,333→ 304,834 total→ Common Stock (1,333 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 3, 2021.